7-HYDROXYSTAUROSPORINE AND IRINOTECAN HYDROCHLORIDE IN TREATING PATIENTS WITH METASTATIC OR UNRESECTABLE SOLID TUMORS OR TRIPLE NEGATIVE BREAST CANCER (CURRENTLY ACCRUING ONLY TRIPLE-NEGATIVE BREAST CANCER PATIENTS SINCE 6/8/2007):